12 Month Price Forecast For MDAI
Distance to MDAI Price Forecasts
MDAI Price Momentum
🤔 Considering Spectral Ai (MDAI)?
Join 5,000+ investors getting our exclusive market analysis every Monday & Thursday. Stay ahead of breakout opportunities.
Disclaimer: The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Data last updated: February 7, 2025 11:55 PM UTC
MDAI Analyst Ratings & Price Targets
Based on our analysis of 3 Wall Street analysts, MDAI has a consensus that is bullish. The median price target is $5.00, with forecasts ranging from $3.00 to $8.10. Currently, there are 4 Buy ratings, 0 Hold ratings, and 0 Sell ratings.
With MDAI currently trading at $1.99, the median price forecast suggests a 151.3% upside. The most optimistic forecast comes from at , projecting a 307.0% upside, while at provides the most conservative target, suggesting a 50.8% upside.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
MDAI Analyst Consensus
MDAI Price Target Range
Latest MDAI Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for MDAI.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Aug 13, 2024 | HC Wainwright & Co. | Swayampakula Ramakanth | Buy | Reiterates | $3.50 |
| Aug 12, 2024 | Northland Capital Markets | Carl Byrnes | Outperform | Initiates | $6.00 |
| Jul 18, 2024 | HC Wainwright & Co. | Swayampakula Ramakanth | Buy | Initiates | $3.50 |
| Jan 23, 2024 | BTIG | Ryan Zimmerman | Buy | Initiates | $4.00 |
Stocks Similar to Spectral Ai Inc
The following stocks are similar to Spectral Ai based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Spectral Ai Inc (MDAI) Financial Data
Spectral Ai Inc has a market capitalization of $42.75M with a P/E ratio of 29.7x. The company generates $27.26M in trailing twelve-month revenue with a -40.8% profit margin.
Revenue growth is +137.6% quarter-over-quarter, while maintaining an operating margin of -10.8% and return on equity of +1,220.2%.
Valuation Metrics
Growth & Margins
Financial Health
🔥 Want More High-Potential Stock Ideas?
Join 5,000+ investors getting our research on stocks with massive upside potential.
Spectral Ai Inc (MDAI) Company Overview
About Spectral Ai Inc
Develops AI-driven predictive medical diagnostics.
The company generates revenue by offering innovative medical diagnostic tools that enhance treatment decisions in wound care, specifically targeting conditions such as burns and diabetic foot ulcers. Its primary products include the DeepView System and DeepView SnapShot M, which utilize advanced AI algorithms and multispectral imaging to provide timely and accurate assessments for clinicians.
Headquartered in Dallas, Texas, Spectral AI focuses on improving patient outcomes through technology. The company addresses a critical need in healthcare by providing tools for faster and more effective treatment interventions, making it a potentially valuable player in the evolving field of medical diagnostics.
Company Information
Sector
Healthcare
Industry
Medical Devices
Employees
78
CEO
Mr. Wensheng Fan
Country
United States
IPO Year
2021
Website
www.spectral-ai.comSpectral Ai Inc (MDAI) Latest News & Analysis
Spectral AI Completes Pediatric Enrollment in Emergency Departments for U.S. Burn Pivotal Study
10 days agoSpectral AI (NASDAQ: MDAI) completed pediatric enrollment for its U.S. Burn Pivotal Study, aimed at validating its AI-driven DeepView® System for predicting burn healing potential.
Completion of pediatric enrollment in a major burn study signals progress for Spectral AI's DeepView® System, potentially driving stock value and market confidence in its AI technology.
Spectral AI Provides Update to Investors
16 days agoSpectral AI (NASDAQ: MDAI) announced an update on its operating results. The company develops the AI-driven DeepView® System, FDA-designated as a Breakthrough Device since 2018.
Spectral AI's update on operating results highlights its FDA-designated technology's potential, influencing investor sentiment on growth prospects and market competitiveness in healthcare.
Spectral AI Provides Instructions for Retail Investors on Exercising Publicly-Traded Warrants
1 month agoSpectral AI (NASDAQ: MDAI) has provided retail investors with instructions for exercising publicly-traded warrants (NASDAQ: MDAIW) related to its AI-driven DeepView® System.
Retail investors can now exercise warrants for Spectral AI, potentially increasing their stake in a company with FDA-designated technology, impacting share price and market sentiment.
Spectral AI (NASDAQ: MDAI) has regained compliance with Nasdaq listing standards, receiving a "moot" letter confirming no further hearings are needed as of December 20, 2024.
Spectral AI's regained Nasdaq compliance alleviates delisting concerns, enhancing investor confidence and potentially stabilizing or boosting its stock price.
Spectral AI (NASDAQ: MDAI) announced it has regained compliance with Nasdaq Listing Rule 5550(b)(2), maintaining a market value of at least $35 million.
Spectral AI's compliance with Nasdaq Listing Rule 5550(b)(2) indicates financial stability, potentially increasing investor confidence and supporting stock value retention.
Spectral AI Incorporates Frontline Feedback into Improved Software Release for Enhanced Diagnostic Precision
1 month agoSpectral AI (NASDAQ: MDAI) has completed software updates for its DeepView SnapShot® M and DeepView AI-Burn® systems in the UK, enhancing performance and usability in medical diagnostics.
Spectral AI's software enhancements for its diagnostic systems improve performance and usability, boosting its competitive edge in the medical tech market and potentially increasing investor confidence.
Frequently Asked Questions About MDAI Stock
What is Spectral Ai Inc's (MDAI) stock forecast for 2025?
Based on our analysis of 3 Wall Street analysts, Spectral Ai Inc (MDAI) has a median price target of $5.00. The highest price target is $8.10 and the lowest is $3.00.
Is MDAI stock a good investment in 2025?
According to current analyst ratings, MDAI has 4 Buy ratings, 0 Hold ratings, and 0 Sell ratings. The stock is currently trading at $1.99. Always conduct your own research and consider your investment goals before making investment decisions.
What is the price prediction for MDAI stock?
Wall Street analysts predict MDAI stock could reach $5.00 in the next 12 months. This represents a 151.3% increase from the current price of $1.99. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is Spectral Ai Inc's business model?
The company generates revenue by offering innovative medical diagnostic tools that enhance treatment decisions in wound care, specifically targeting conditions such as burns and diabetic foot ulcers. Its primary products include the DeepView System and DeepView SnapShot M, which utilize advanced AI algorithms and multispectral imaging to provide timely and accurate assessments for clinicians.
What is the highest forecasted price for MDAI Spectral Ai Inc?
The highest price target for MDAI is $8.10 from at , which represents a 307.0% increase from the current price of $1.99.
What is the lowest forecasted price for MDAI Spectral Ai Inc?
The lowest price target for MDAI is $3.00 from at , which represents a 50.8% increase from the current price of $1.99.
What is the overall MDAI consensus from analysts for Spectral Ai Inc?
The overall analyst consensus for MDAI is bullish. Out of 3 Wall Street analysts, 4 rate it as Buy, 0 as Hold, and 0 as Sell, with a median price target of $5.00.
How accurate are MDAI stock price projections?
Stock price projections, including those for Spectral Ai Inc, are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
